ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note
BGC0000547.1|Salivaricin_1 # 619 # 5316 # 1 # ID=1_1;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=12bp;gc_cont=0.458	BGC0000547.1|Salivaricin_1 	619	5316	+	Loose	500	26.9498	NDM-9	28.12	3002359	protein homolog model	n/a	n/a	carbapenem; cephalosporin; cephamycin; penam	antibiotic inactivation	NDM beta-lactamase	ATGGAAAATAAGGTACGTTTTAAACTACACAAGGTTAAGAAAAACTGGGTAACTATCGGGGTGACCACTCTCTCAATGGTTGCCTTGGCAGGTGGAAGCCTCCTAGCTCAAGGAAAAGTAGAGGCCGATGAGACGAGCGCACCTAACGGTGACGGCTTGCAGCAACTGAGTGAGGATGGGACTGCCAGTCTAGTGATGACAACAACTGTTACTGAGCAAGCTAGTGCGCAAGCAAGTGTGTCAGCAATAGAAACAGTTGGAACAAACTCACAGGTGGTGACAAGTGTGGTCAGCCAAGAGACAACTGCTCAAGTACAAACTAGTCCAGTTGCCAGTCGGGAAGTGGCAGTTTCTTCGCAAACTCAAGCTAGTGCCCAAGAGACACAGACTACGGAACAGGCCTCACAAGGTCAGACATCAACTCAAGTAGCTGGGCAAACAAGTACTCAGTCCACTCCTAGAGTCTTGACCAATGCTGCACCAGCAATCGCCACACGCGCTGCTGACAGCACTATTCGTATCAATGCCAACCGCAACACTAACATCACGATTACGGCCAGCGGTACGACACCAAATGTAACCATTATCACAGGACCAAACACTCCTAAGCCAAACGTGACGGTGACAAGTCCAAATGGCACAAGACCAAATGTGACCATTGTAACGCAGCCAAATCAACCAAACAAACCTGTTCAACCGAGTCAACCGTCTCAACCTAATAAGCCAGTCCAACCAAGTCAGCCAAGTCTTGACTATAAACCAGTAGCTTCCAACTTGAAGACTATTGATGGCAAGCAGTATTATGTTGAAAATGGCGTTGTGAAAAAGAACACAGCGATTGAACTTGATGGTCGTCTTTATTATTTCGATGAGACTGGGGCTATGGTGGATCAAAGTAAACCTTTGTATCGTGCCGATGCCATTCCAAATAACTCTATCTATGCGGTTTATAACCAGGCCTACGACACGTCAAGCAAGAGTTTTGAACACTTGGACAATTTCTTGACGGCTGATAGCTGGTATCGTCCAAAACAGATCTTGAAGGACGGGAAAAATTGGACAGCTTCAACTGAGAAAGATTATCGTCCCCTTTTGATGACTTGGTGGCCAGACAAGGTGACACAAGTCAACTACCTCAACTATATGAGTCAACAAGGCTTTAGTGATAAGGCCTATACGACTGACATGATGAGCTATGACTTGGCAGCTGCTGCCGAAACGGTGCAACGAGGAATTGAGGAACGTATTGGTCGCGAGGGCAATACCACTTGGCTTCGCCAGTTGATGTCAGATTTCATCAAAACACAGCCTGGCTGGAACTCTGAGAGTGAGGACAATCTCTTAGTTGGTAAAGACCACTTGCAAGGAGGCGCACTGACTTTCCTCAATAATAGTGCGACAAGTCATGCCAATTCAGACTTCCGCCTCATGAACCGCACACCGACTAACCAAACGGGGACACGCAAATACCATATTGACCGTTCAAATGGTGGTTACGAGTTGCTCTTGGCAAACGATATCGACAACTCTAACCCAGCTGTTCAGGCTGAACAACTAAACTGGCTCCACTACATCATGAATATTGGTTCTATCCTTGGCAATGATCCAAGTGCCAACTTTGACGGTGTTCGTATCGATGCGGTGGACAATGTGGATGCGGACCTCTTGCAAATTGCTTCTGACTACTTCAAGGAAAAATACCGTGTGGCTGACAATGAAGCCAACGCCATTGCTCACTTGTCAATCCTTGAAGCTTGGTCCTACAATGACCACCAATACAACAAGGATACCAAGGGTGCTCAGTTGTCCATTGACAATCCACTACGTGAAACGCTTTTGACAACTTTCTTGCGTAAGAGCAATTACCGTGGCAGCTTGGAGCGCGTGATTACTAACTCTCTTAACAACCGTTCAAGTGAGCAGAAACACACGCCACGTGATGCCAATTATATTTTCGTGCGAGCCCATGATAGTGAAGTGCAAGCTGTTTTGGCCAATATCATCAGCAAGCAGATTAATCCAAAAACAGATGGTTTCACCTTCACTATGGATGAGCTCAAACAGGCTTTTGAAATCTACAATGCGGACATGCGCAAGGCTGATAAAAAGTACACCCAGTACAATATCCCAGCTGCCTATGCCACAATGTTGACCAACAAGGATAGTATCACTCGTGTTTACTACGGAGATCTCTTTACCGACGATGGCCAATACATGGCTGAAAAATCACCATACTATAATGCCATCAATGCCCTGCTTCGTGCTCGCATTAAATATGTAGCAGGTGGTCAAGACATGAAGGTTACTAAGCTTAATGGCTATGAAATCATGTCATCTGTACGTTATGGTAAGGGGGCAGAAGAAGCCAACCAACTTGGTACTGCCGAGACACGCAACCAAGGAATGCTCGTCCTTACAACCAACCGTCCAGATATGAAGTTGGGGGCAAATGACCGTTTGGTGGTCAATATGGGAGCTGCCCACAAAAATCAGGCCTACCGTCCATTGCTTCTCAGCAAATCGACAGGTCTTGCGACCTACCTCAAGGATTCTGATGTGCCAGCTGGATTGGTTCGCTATACGGATAATCAAGGGAACTTGACCTTCACGGCAGACGATATTGCTGGTCATTCAACCGTTGAAGTTTCAGGTTATTTGGCAGTTTGGGTGCCAGTAGGTGCTTCTGAAAACCAAGATGCCCGTACCAAGGCTTCGAAGACTAAGAAGGGTGAGCAGGTCTTTGAATCATCAGCAGCTCTTGACTCACAAGTCATTTACGAAGGCTTCTCAAACTTCCAAGATTTCGTTAAGATACCAAGTCAGTACACCAACCGTGTTATTGCTCAAAATGCCAAACGCTTCAAAGAGTGGGGAATCACTTCCTTTGAATTTGCGCCACAATACGTGTCTAGCCAAGACGGCACTTTCTTGGATTCTATCATTGAAAATGGCTATGCCTTCGAGGACCGTTACGATATTGCCATGAGCAAGAACAACAAATACGGTTCACTCAAAGACCTCATGGATGCTCTTCGTGCCCTTCACGCTGAAGGTATCTCAGCCATTGCTGACTGGGTTCCAGATCAAATTTACAATCTCCCTGGAAAAGAAGTGGTAACAGCTTCACGTACCAACAGCTACGGCACACCACGTCCAAATGCTGAAATCTACAATAGTCTCTATGCAGCTAAAACACGTACCTTTGGAAATGACTTCCAAGGCAAGTACGGAGGTGCCTTCCTTGATGAATTGAAGGCAAAATACCCAGCTATCTTTGAGCGCGTGCAGATTTCAAACGGCCGTAAATTGACTACAAATGAGAAAATCACGCAATGGTCAGCCAAGTATTTCAATGGAAGCAATATCCAAGGTACAGGGGCTCGCTATGTCTTGCAAGATAACGCAACAAACCAATACTTCAACCTGAAAGCAGGTCAAACCTTCCTTCCTAAACAAATGACAGAAATCACAGCAACTGGTTTCCGTAGGGTGGGAGATAAGGTCCAATACCTCTCAACGAGTGGCTACCTTGCCAAGAATACCTTCATTCAAATCGGTGCCAACCAGTGGTATTACTTTGATAAGAACGGTAACATGGTCACAGGTGAACAGGTCATTGATGGCAAGAAATACTTCTTCCTAGACAATGGGCTTCAGCTACGTCATGTTCTTCGCCAAGGCAGTGATGGTCACGTCTATTACTACGATCCTAAAGGGGTTCAGGCCTTTAACGGATTCTACGACTTTGCAGGTCCTCGCCAAGATGTTCGCTATTTTGATGGTAACGGTCAAATGTATCGTGGTCTCCACGACATGTATGGCACAACCTTCTATTTCGATGAAAAGACTGGTATTCAAGCTAAAGACAAGTTCATCCGCTTTGCGGACGGTCGCACACGTTACTTCATTCCAGATACAGGAAATCTCGCAGTTAACCGTTTTGCGCAAAATCCTGAAAACAAGGCTTGGTATTTCCTCGATAGCAACGGTTATGCCGTGACAGGTCTTCAAACGATTAACGGTAAGCAGTATTACTTTGACAATGAAGGACGTCAGGTTAAGGGACACTTTGTCACTATCAATAACCAACGTTACTTCCTTGATGGCGATAGCGGTGAAATTGCTCGTTCACGCTTTGTGACGGAAAACAACAAGTGGTACTATGTCGATGGCAATGGTAAGCTGGTTAAAGGCGCTCAAGTTATCAATGGTAATCACTACTATTTCAACAATGATTATAGCCAAGTCAAGGGTGCCTGGGCTAACGGCCGTTACTATGATGGTGACTCAGGTCAGGCCGTAACCAACCGCTTTGTCCAAGTCGGTGCCAACCAATGGGCTTACCTCAACCAAAATGGTCAAAAGGTAGTCGGTCTCCAGCATATCAATGGTAAACTTTACTACTTTGAAGGCAACGGTGTCCAAGCTAAAGGGAAACTTCTGACTTACAGAGGTAAGAAATACTACTTTGATGCCAATAGTGGTGAAGCCGTAACCAATCGCTTTATCCAAATTTCTCGTGGTGTTTGGTATTACTTTAACGCCTCAGGCCAAGCCGTAACAGGTGAGCAAGTCATCAACGGTCAACACCTCTACTTTGACGCTTCTGGCCGTCAGGTCAAAGGCCGTTACGTCTGGGTTAAAGGCCAACGCCGTTACTATGACGCCAATACTGGAGCTTGGGTCAGAAAACGATAA	MENKVRFKLHKVKKNWVTIGVTTLSMVALAGGSLLAQGKVEADETSAPNGDGLQQLSEDGTASLVMTTTVTEQASAQASVSAIETVGTNSQVVTSVVSQETTAQVQTSPVASREVAVSSQTQASAQETQTTEQASQGQTSTQVAGQTSTQSTPRVLTNAAPAIATRAADSTIRINANRNTNITITASGTTPNVTIITGPNTPKPNVTVTSPNGTRPNVTIVTQPNQPNKPVQPSQPSQPNKPVQPSQPSLDYKPVASNLKTIDGKQYYVENGVVKKNTAIELDGRLYYFDETGAMVDQSKPLYRADAIPNNSIYAVYNQAYDTSSKSFEHLDNFLTADSWYRPKQILKDGKNWTASTEKDYRPLLMTWWPDKVTQVNYLNYMSQQGFSDKAYTTDMMSYDLAAAAETVQRGIEERIGREGNTTWLRQLMSDFIKTQPGWNSESEDNLLVGKDHLQGGALTFLNNSATSHANSDFRLMNRTPTNQTGTRKYHIDRSNGGYELLLANDIDNSNPAVQAEQLNWLHYIMNIGSILGNDPSANFDGVRIDAVDNVDADLLQIASDYFKEKYRVADNEANAIAHLSILEAWSYNDHQYNKDTKGAQLSIDNPLRETLLTTFLRKSNYRGSLERVITNSLNNRSSEQKHTPRDANYIFVRAHDSEVQAVLANIISKQINPKTDGFTFTMDELKQAFEIYNADMRKADKKYTQYNIPAAYATMLTNKDSITRVYYGDLFTDDGQYMAEKSPYYNAINALLRARIKYVAGGQDMKVTKLNGYEIMSSVRYGKGAEEANQLGTAETRNQGMLVLTTNRPDMKLGANDRLVVNMGAAHKNQAYRPLLLSKSTGLATYLKDSDVPAGLVRYTDNQGNLTFTADDIAGHSTVEVSGYLAVWVPVGASENQDARTKASKTKKGEQVFESSAALDSQVIYEGFSNFQDFVKIPSQYTNRVIAQNAKRFKEWGITSFEFAPQYVSSQDGTFLDSIIENGYAFEDRYDIAMSKNNKYGSLKDLMDALRALHAEGISAIADWVPDQIYNLPGKEVVTASRTNSYGTPRPNAEIYNSLYAAKTRTFGNDFQGKYGGAFLDELKAKYPAIFERVQISNGRKLTTNEKITQWSAKYFNGSNIQGTGARYVLQDNATNQYFNLKAGQTFLPKQMTEITATGFRRVGDKVQYLSTSGYLAKNTFIQIGANQWYYFDKNGNMVTGEQVIDGKKYFFLDNGLQLRHVLRQGSDGHVYYYDPKGVQAFNGFYDFAGPRQDVRYFDGNGQMYRGLHDMYGTTFYFDEKTGIQAKDKFIRFADGRTRYFIPDTGNLAVNRFAQNPENKAWYFLDSNGYAVTGLQTINGKQYYFDNEGRQVKGHFVTINNQRYFLDGDSGEIARSRFVTENNKWYYVDGNGKLVKGAQVINGNHYYFNNDYSQVKGAWANGRYYDGDSGQAVTNRFVQVGANQWAYLNQNGQKVVGLQHINGKLYYFEGNGVQAKGKLLTYRGKKYYFDANSGEAVTNRFIQISRGVWYYFNASGQAVTGEQVINGQHLYFDASGRQVKGRYVWVKGQRRYYDANTGAWVRKR	MELPNIMHPVAKLSTALAAALMLSGCMPGEIRPTIGQQMETGDQRFGDLVFRQLAPNVWQHTSYLDMPGFGAVASNGLIVRDGGRVLVVDTAWTDDQTAQILNWIKQEINLPVALAVVTHAHQDKMGGMDALHAAGIATYANALSNQLAPQKGMVAAQHSLTFAANGWVEPATAPNFGPLKVFYPGPGHTSDNITVGIDGTDIAFGGCLIKDSKAKSLGNLGDADTEHYAASARAFGAAFPKASMIVMSHSAPDSRAAITHTARMADKLR	579.63	gnl|BL_ORD_ID|1103|hsp_num:0	1168		
BGC0000547.1|Salivaricin_2 # 5620 # 5931 # 1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=GGGG;rbs_spacer=6bp;gc_cont=0.365	BGC0000547.1|Salivaricin_2 	5620	5931	+	Loose	500	29.261	TEM-213	34.69	3001390	protein homolog model	n/a	n/a	monobactam; cephalosporin; penam; penem	antibiotic inactivation	TEM beta-lactamase	ATGACAAGTAAGAAAGAAGATTTGCTAACGCTTTGGGTAATGTTCTTGATAGGTCTTGTAGCTATTTTCGGTGGTGCGATTTATATGAACCATAAAAAAGAACAAGGTTTGTACAAACATGGTTTCAGGCTTTTGGAAGAACAGATTGGAAGTTATGTTATTGAACATTATTCAGGGGTTGAAAAGGTTGAGTTTTCACCAATTTTTATTAATACTGATGGGATGTTTACCGCAAAAGTTGTGCCTGTAATCTATGATTTGCACGGAAATAAAGCCTACCTTGGTCGACCAGTAAAAGGTGGGAGAGATTGA	MTSKKEDLLTLWVMFLIGLVAIFGGAIYMNHKKEQGLYKHGFRLLEEQIGSYVIEHYSGVEKVEFSPIFINTDGMFTAKVVPVIYDLHGNKAYLGRPVKGGRD	MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEFSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW	36.01	gnl|BL_ORD_ID|667|hsp_num:0	709		
BGC0000547.1|Salivaricin_3 # 6389 # 6586 # 1 # ID=1_3;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=6bp;gc_cont=0.404	BGC0000547.1|Salivaricin_3 	6389	6586	+	Loose	700	25.7942	adeS	41.67	3000549	protein homolog model	n/a	n/a	glycylcycline; tetracycline antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGAGTAAAGCAAGCTCAGAAATCGCTATTCTTGTAAATAGTGAAAGGGTTCATTGCTATACTATGCCTAATGACATTATCGGATTTTCTCATCTACTGAAGGATCTAAAGACCGTGAGCACCCCCCGAAATTATTTTCGAAGCTACTGGTGTCTACTCTCGACGACTTCAGGCTTTTCTAGAAGAAAACAGCTATGA	MSKASSEIAILVNSERVHCYTMPNDIIGFSHLLKDLKTVSTPRNYFRSYWCLLSTTSGFSRRKQL	MKSKLGISKQLFIALTIVNLSVTLFSIVLGYIIYNYAIEKGWISLSSFQQEDWTSFHFVDWIWLATVIFCGCIISLVIGMRLAKRFIVPINFLVEAAKKISHGDLSARAYDNRIHSAEMSELLYNFNDMAQKLEVSVKNAQVWNAAIAHELRTPITILQGRLQGIIDGVFKPDEVLFKSLLNQVEGLSHLVEDLRTLSLVENQQLRLNYELFDLKAVVEKVLKAFEDRLDQAKLVPELDLTSTPVYCDRRRIEQVLIALIDNAIRYSNAGKLKISSEVVADNWILKIEDEGPGIATEFRDDLFKPFFRLEESRNKEFGGTGLGLAVVHAIIVALKGTIKYSNQGSKSVFTIKISMGHEEMG	18.01	gnl|BL_ORD_ID|169|hsp_num:0	183		
BGC0000547.1|Salivaricin_4 # 6606 # 7157 # 1 # ID=1_4;partial=00;start_type=TTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.397	BGC0000547.1|Salivaricin_4 	6606	7157	+	Loose	700	27.335	Mef(En2)	28.12	3004659	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	TTGGAAGCTAAGAAGCAACTTGATGGATTACGAGTTCGGAAAACCGATAAGATTGATGCAGAGAAACTAGCTTCGTCACAATTCGTTTTAAGCCGTAAGCCAACTTACGTTCAAGAAGAAGTCTATCAAAACTTGCATGATCTTAGCCGATTCTACCAAAATCTGACAGAGGATATCGTAAGGACGAAGAATAGGCTGCACAAAGTTCTTCAAGTCGCCTTCCCAGAAATCGAGATTCTACTATTTATTCCTACAGGTGAGCAATATTGGAATCTCGTGTCCATCTTCCCAACAAAGCATTGGGTGTTGGAATTATCAGAAGTTGAGTTGAAAGAGACTATTCGCAACTCAACCTCTAAACGCATTTCAGAGAACAGAGTAGGTAACTTGGCTGAGAAGTTAGTTGGACTGGCAAAGCAATCGTATTCTGCCACTTCAAAAACCTCTCCTATGATAGAAGAGGTTAAGTATAATGGCTCTATAATTTCTGTAGTGGGTAAAACCACTGTAGAGATTATAGAGCTTTTTGAGTGTACACAAAAAGTCCCATAA	MEAKKQLDGLRVRKTDKIDAEKLASSQFVLSRKPTYVQEEVYQNLHDLSRFYQNLTEDIVRTKNRLHKVLQVAFPEIEILLFIPTGEQYWNLVSIFPTKHWVLELSEVELKETIRNSTSKRISENRVGNLAEKLVGLAKQSYSATSKTSPMIEEVKYNGSIISVVGKTTVEIIELFECTQKVP	MNHWKSTLAVIGIGQLISILTSTIVGFSIIFWISNEFKSPTALSLAILAGFLPQFVLGLFAGVYVDRWNRKKTMFYSDLFIAFCTLCLFIVITKGYKDLSFFYLLTACRSIGSTFHAPALQASIPLLVPKHHLVRVSGLYHSIQSFSEVIAPVVGASLVVWLPIQYILLIDVIGAVAACLTLLCVQIPSLQKTKVLPDFKKELTEWLHTLRRTMGILPLFVCFTLVTFVLMPVFTLFPFMTLLHFNGNILQMGVVEMGWGSGALLGGLVLACKALKSKQTLVMHTAYVILGLYLISASYLPSSAFIGFVCLTFTGGIAYSIYHALFIAIIQQNLASDMLGRTFSLIFSLSTFPSMLGIVASGYWVEAWGITSVFMISGWVIFLIGVGANFISSIKQLDNYA	45.64	gnl|BL_ORD_ID|2256|hsp_num:0	3359		
BGC0000547.1|Salivaricin_5 # 7201 # 8019 # 1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=7bp;gc_cont=0.396	BGC0000547.1|Salivaricin_5 	7201	8019	+	Loose	782	26.1794	CMY-150	34.48	3005016	protein homolog model	n/a	n/a	cephamycin	antibiotic inactivation	CMY beta-lactamase	ATGAGACTTATTAAGAATACCACAGAATTAATCGGAATTAAAGACCAAAACATCAAGATTTCACTTGTTTTTGAAACTAACACTCATTTAGAGATTCAAGCAAAACTTGATTATCCTGCACCATCATGTCCTCATTGCCATGGAAAAATGATCAAGTACGACTTTCAAAAGCCTTCTAAAATCCCTCTTCTCGAGCAAGCGGGAACTCCAACTCTACTACGTCTGAAGAAGCGTCGTTTCCAGTGTAAAAATTGTAGGAGAGTCACGGTAGCTGAGACATCAATCGTTGAGAAAAACTGCCAAATCTCCAATCTAGTCCGACAAAAGGTTGCACAACTCTTGACTCAGAAGATGTCATTAACGGATATTGCCAGAAGACTTCGTGTGTCGACATCCACTGTCTATCGTAAGCTCGACCAGTTTACTTTCAAGGAACATTATGACAAACTTCCAGCTGTTATGTCCTGGGATGAGTTTGGATTCAAGAAAGGGGAATTGGCTTTTGTAGCGCAGAATTATGAGACCAACCAACTCATAACCATCCTTGATAATCGCCGCCAAACCACTATACGAAACTACTTTTTAAAGTATCCATTAAAAGCTCGCCAAAAGGTACAGTTTATCACGATGGATATGTCCGGAGCTTATATTCCACTTGCCAAAAGACTTTTTCCAAACGCTAAAATCGTTCTTGATCGTTTCCACATTATCCAGCACCTTGGTCGTGCCTTTTTAAAGACAAGAATTATGATTATGAACCAATTCGATAAGAAGTCACTACCCTATCGAGCCTTGAAAAATCATTGGCGACTCTTCTAA	MRLIKNTTELIGIKDQNIKISLVFETNTHLEIQAKLDYPAPSCPHCHGKMIKYDFQKPSKIPLLEQAGTPTLLRLKKRRFQCKNCRRVTVAETSIVEKNCQISNLVRQKVAQLLTQKMSLTDIARRLRVSTSTVYRKLDQFTFKEHYDKLPAVMSWDEFGFKKGELAFVAQNYETNQLITILDNRRQTTIRNYFLKYPLKARQKVQFITMDMSGAYIPLAKRLFPNAKIVLDRFHIIQHLGRAFLKTRIMIMNQFDKKSLPYRALKNHWRLF	MMKKSICCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYEGKPYYFTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQWRGISLLHLATYTAGGLPLQIPDDVTDKAELLRFYQNWQPQWTPGAKRLYANSSIGLFGALVVKHSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKNYAWGYREGKPVHVSPGQLDAEAYGVKSSVIDMARWVQANMDASLVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPLKADSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLANKSYPNPARVEAAWRILEKLQ	71.39	gnl|BL_ORD_ID|2809|hsp_num:0	3760		
BGC0000547.1|Salivaricin_6 # 8517 # 8720 # 1 # ID=1_6;partial=00;start_type=TTG;rbs_motif=GGA;rbs_spacer=10bp;gc_cont=0.402	BGC0000547.1|Salivaricin_6 	8517	8720	+	Loose	2130	25.7942	mtrD	34.48	3000811	protein homolog model	n/a	n/a	macrolide antibiotic; penam	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	TTGACAAACCGTCGGGAACAAGTTTTAGAACAGTTGGTAGAGTTAGCTAAACCTCTACCTGAATATGAGATTCTTCTCTCTATTCCTGGTATCGCAGAAACAACGGCTACAAGCGTTATTGGCGAATTAGGAGACATTCGTCGCTTTAAGTCTGCTAATCAAATCAACGCTTTTATCGGTATTGATCTCAACCACTATGAATAG	MTNRREQVLEQLVELAKPLPEYEILLSIPGIAETTATSVIGELGDIRRFKSANQINAFIGIDLNHYE	MAKFFIDRPIFAWVISIFIIAAGIFGIKSLPVSQYPSVAAPTITLRATYPGASAQVMEDSVLSVIERNMNGVEGLDYMSTSADSSGSGSVSLTFTPDTDENLAQVEVQNKLSEVLSTLPATVQQYGVTVSKARSNFLMIVMLSSDVQSTEEMNDYAQRNIVPELQRIEGVGQVRLFGAQRAMRIWVDPKKLQNYNLSFADVGSALSAQNVQISAGSIGSLPAVRGQTVTATVTAQGQLGTAEEFGNVILRANTDGSNVYLKDVARVGLGMEDYSSSTRLNGVNTTGMAVMLSNSGNAMATAKAVKERMATLEKYFPQGMSWKTPYDTSKFVEISIEKVIHTLIEAMVLVFVVMYLFLQNIRYTLIPTIVVPISLLGGFAFISYMGMSINVLTMFAMVLVIGIVVDDAIVVVENVERIMAGEGLPPKEATKKAMGQISGAVIGITAVLISVFVPLAMFSGATGNIYKQFALTMASSIAFSAFLALTLTPALCATMLKTIPKGHHEEKKGFFGWFNKKFNSWTHGYEGRVAKVLRKTFRMMVVYIGLAVVGVFLFMRLPTSFLPTEDQGFVMVSVQLPAGATQERTNATLAQVTQLAKSIPEIENIITVSGFSFSGSGQNMAMGFAILKDWNERTAPGSDAVAIAGKLTGMMMGTLKDGFGIAVVPPPILELGNGSGLSINLQDRNNTGHTALLAKRNELIQKMRASGLFDPSTVRAGGLEDSPQLKIDINRAAAAAQGISFADIRTALASALSSSYVSDFPNQGRLQRVMVQADEDARMQPADILNLTVPNKSGVAVPLSTIATVSWENGTEQSVRFNGYPSMKLSASPATGVSTGQAMAAVQKMVDELGGGYSLEWGGQSREEAKGGSQTLILYGLAVAAVFLVLAALYESWSIPLAVILVIPLGLIGAAAGVTGRNLFEGLLGSVPSFANDIYFQVGFVTVMGLSAKNAILIIEFAKDLQAQGKSAVEAALEAARLRFRPIIMTSFAFILGVVPLYIAGGASSASQRAIGTTVFWGMLIGTLLSVFLVPLFYVVVRKFFKETAHEHEMAVKHAAEAGITGSDDSQH	6.28	gnl|BL_ORD_ID|1829|hsp_num:0	1938		
BGC0000547.1|Salivaricin_7 # 8767 # 8973 # 1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=6bp;gc_cont=0.362	BGC0000547.1|Salivaricin_7 	8767	8973	+	Loose	850	21.1718	QepA2	27.91	3004103	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGCAAGAAAAATTCTGTACAAATGTATTCACAATATCGCTGCAGCTAGCCATACCAATCCTTGCCATATCGCAGATTTCTATGAGAAACGCAAAAGACAATCGCAGACAACTTCAACCAAGCCACACACGATTGCCTCTATACATCGCCTTATTAGGACAATATATTATCTTAAAATGCATAATAAACTTTACGACTATACTTTAG	MQEKFCTNVFTISLQLAIPILAISQISMRNAKDNRRQLQPSHTRLPLYIALLGQYIILKCIINFTTIL	MSATLHDTAADRRKATRREWIGLAVVALPCLVYAMDLTVLNLALPVLSRELQPSSAQLLWILDIYGFFVAGFLITMGTLGDRIGRRRLLLIGAAFFAFGSVLAALADTAALLIAARALLGLAGATIAPSTMALIRNMFHDPRQRQFAIGVWIAAFSLGSAIGPLVGGVLLEFFHWGAVFWLNVPVMLLTLALGPRFLPEYRDPDAGHLDLASVLLSLAAVLLTIYGLKQLAEHGAGLASMAALLAGLAVGALFLRRQGHIAYPLLDLRLFAHAPFRAALAAYALAALAMFGVYIFMTQYLQLVLGLSPLQAGLATLPWSLCFVIGSLLSPQLAARWPAARILVVGLSAAAFGFAVLGLGQGLWWLVPATIVMGLGLAPVFTIGNEIIITSAPSERAGAASALSETVSEFSGALGIALFGSVGLVVYRQALTSAALPGLPADALQAAGASLGGAVHLADTLPAWQGAALLAAARAGFTDALQATAWAGAVLVLVAAGLVARLLRKRPALASG	13.31	gnl|BL_ORD_ID|2457|hsp_num:0	2771		
BGC0000547.1|Salivaricin_8 # 9198 # 10565 # -1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=7bp;gc_cont=0.292	BGC0000547.1|Salivaricin_8 	9198	10565	-	Loose	910	78.1814	smeS	21.98	3003067	protein homolog model	n/a	n/a	aminoglycoside antibiotic; cephalosporin; cephamycin; penam	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGTTTAAACTACGTGTAGTAACACAATTTATTAGACGTTTTATTGTTTCAGTCATAGTAATGTCCATAATAAACATTTTTATTATAGTTTTTTTTGTTTTTAGCCAAGCAAATCAAACTAATGTGATGGATACAGTGAGTAGCCTAGTCAAACAACTTGATATCAGTTCTAATTCTGCCAAATTATCTAACTTGGGTAAAAAATTAGCTAATTCTAAAGAGGTATGGATTATGGTTTTAGACTCTGATAGTGGAAAGGAAATTTATGAATATAAAAAGCCAAGTGAAGTCCCAACACAGTATAGTCTAACTGACGTCGCTAAGTTTACACGTTATTATTTAAATGATTACCCTGTATTCGTACAAATTATTAACAATAAGATTCTTGTTTTTGGATTTTCAAAAGATAATGTGTTTAAATTTCCTTTCAATTATTATGAAAAATCCGACCTTCACAACCTCTTTATTTTAGCTTTTTTTCTACTTGGAATAAATTGCCTGTATCTATTAATCATTTATACCTATAGTACTAGAGTAGTCCAACGTAAAATTACCCCTTTAGTTTCAGCAATTCAAAAACTACCAGAAGGCCTAAGTGGCTCTGTTGCAACTCAAGATGAGCTAAAACAATTAACGGAGGCTATAAATATTGCTGACAATAAACTTAAAGAAGGGGAGCTTTTTAAAGAAAATTGGATTTCTGGTATAGCACATGATATAAAGACACCTCTGTCCGTTATTATTTCAAATGCTTCTCTTATTAAGTCTGATACAGCAGATAAAAATCAATTAAGACGTTTACGATCCATCCTTAATGAGAGCTATTATATTCAAAACACTATAAATGACTTAAATATTTTTGCCAGATTAACTAATAACCAGTTTAGTCTAAAACTAGAATCAGTCAAAATAATTTCTTTCTTCAGGAAAATCATTATACAAATAATAAATCAAGAAGTCTGGGAAAATTCAAATTTTGCATTTGAATTTGATGATAAACTTCAAAATAGTACAATTTCAATTGAGAAAAACTTAATTTCACGCGTACTTCATAATATTATATATAACTCAATTCTCCATAATCCCGAAGGCTGCAATGTGAATATTCGTCTACACAGAGATAAAGAATTTTTAATAATTACAATTGAGGATAATGGCATAGGCATAACAAATGATAAGCTATTATCAATTCATAATAGTAATAAAATCATTGAAGAATTTGACATCTCAGGAATTAGACGACACGGTATGGGATTAAAAATCTCAAAACAAATTATCGAAGTTCATGAGGGAAGCTTTAAAGTGGAAAGTAAAGAGAAACAATTCTTTAGAGTTATAATTACTTTACCTTTAGAAGGTGAAGTATAA	MFKLRVVTQFIRRFIVSVIVMSIINIFIIVFFVFSQANQTNVMDTVSSLVKQLDISSNSAKLSNLGKKLANSKEVWIMVLDSDSGKEIYEYKKPSEVPTQYSLTDVAKFTRYYLNDYPVFVQIINNKILVFGFSKDNVFKFPFNYYEKSDLHNLFILAFFLLGINCLYLLIIYTYSTRVVQRKITPLVSAIQKLPEGLSGSVATQDELKQLTEAINIADNKLKEGELFKENWISGIAHDIKTPLSVIISNASLIKSDTADKNQLRRLRSILNESYYIQNTINDLNIFARLTNNQFSLKLESVKIISFFRKIIIQIINQEVWENSNFAFEFDDKLQNSTISIEKNLISRVLHNIIYNSILHNPEGCNVNIRLHRDKEFLIITIEDNGIGITNDKLLSIHNSNKIIEEFDISGIRRHGMGLKISKQIIEVHEGSFKVESKEKQFFRVIITLPLEGEV	MAFAMAKFQLKFGLTAKTFLAIFTACLLVLAVNGIASRVAFQTGFLDYLNDQGDLRMQRLMPHLQREYREHGGWEHLHGDGDRWARLLRPDLAHGHEGPVPSLSDQTGVPSRLGLFDAQHRFVAGNPDATSDDEPHAVQVDGQTVGWLGMVPFQTVIATNDLNFYNTQVRAWWVIGIALLLVTVLLAWLVSRALRQRLAKLAAATHRLAAGDYATRIERTSDDELDALVNDFNRMAQALDDTERNRRAFIADISHELRTPLAVVRAELEAIEDGIRPLDRANLVGLQGEIRQLGKLIDDLHDLSMTQSGGLAYRFAPLDLVALLRSELNGMRVRFANAGLALEEDLPATPLQVSGDERRLQQVLANLLENALRYTHAGGRVRVQAARVPAGVQLVVEDTAPGVPPDKCALVFERFYRVESSRNRASGGSGLGLAISHNIILAHHGVIHAAPSPLGGLRVVITLPEPA	97.43	gnl|BL_ORD_ID|319|hsp_num:0	342		
BGC0000547.1|Salivaricin_9 # 10577 # 11275 # -1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=GGAGA;rbs_spacer=4bp;gc_cont=0.309	BGC0000547.1|Salivaricin_9 	10577	11275	-	Loose	400	147.517	vanRI	36.36	3003728	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanR	ATGGATATCGAAGCGCCTTTTTTGGCTAGGAAAATATTGGTTGTTGATGATGATGTTGCGTTAAATCATTCAATAAGGGAGATACTGTCAGTTTCTGGTTTCTCAAAAATATATAGTGCATACAGCATCAGTGAAGGAATAGAGTCTTTTGTTAAAAATTCTATTGATTTGATTATATTAGATGTCATGCTTCCTGACGGGGAAGGGTATTTATTATCAAAATATGTTAGAAAAGAATCTGATATTCCAATTCTTTTTCTAACAGCAAAAAATGAACCTGAAGATGAAATTCAAGGTCTACAATCTGGAGGAGATGATTTTATAACTAAGCCTTTCCTACCTAAAATTCTCATTTATCGTACGATTTCGCTTCTTCGGCGATCGTACAAAGAAGACAGTAATACTATTAAATTAGATCATTGTATTATTAATTTAGGGAATGCAATTGTTGAAAAAGATAATGAAAAATTATCTTTAACCCCAATAGAAATTCAAATCATTCGAAAATTGTATGATAATAAAAACTATATTGTATCTACAGAAGCGATTTGTGATACAGTATGGGGTATTGATAGCTTTGGATATGAAAAATCTTTAATGGTTCATATTAGAAATATCAGAGAAAAAATCGAACTTAATCCTTCAAAGCCACAATACTTGGTTACTGTTAAAGGACTTGGCTACAAACTAATGGTGTAG	MDIEAPFLARKILVVDDDVALNHSIREILSVSGFSKIYSAYSISEGIESFVKNSIDLIILDVMLPDGEGYLLSKYVRKESDIPILFLTAKNEPEDEIQGLQSGGDDFITKPFLPKILIYRTISLLRRSYKEDSNTIKLDHCIINLGNAIVEKDNEKLSLTPIEIQIIRKLYDNKNYIVSTEAICDTVWGIDSFGYEKSLMVHIRNIREKIELNPSKPQYLVTVKGLGYKLMV	MAANILIVDDEQAIADLVEVYLKNENYNLFKFYNGKDALDCIEKEKLDLAILDVMLPDVDGFSICRQIREKHNFPVIMLTAKEEEIDKITGLTLGADDYITKPFRPLELIARVKAQLRRFTKYNSAEPNQEEHVIAFSGLVLDMDTHECTLNEKKLSLTPTEFSILWVLCSNRGRVVSSEELFSEVWGDKYFTNSNNTVMVHIRHLREKMQDSAEHPKYIKTVWGVGYKIEK	100.00	gnl|BL_ORD_ID|2093|hsp_num:0	2246		
BGC0000547.1|Salivaricin_10 # 11473 # 11643 # 1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=GGAG;rbs_spacer=8bp;gc_cont=0.351	BGC0000547.1|Salivaricin_10 	11473	11643	+	Loose	1050	25.0238	srmB	39.29	3002828	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; tetracycline antibiotic; oxazolidinone antibiotic; phenicol antibiotic; pleuromutilin antibiotic	antibiotic target protection	ABC-F ATP-binding cassette ribosomal protection protein	ATGAAATCAACAAATAATCAAAGTATCTCAGAAATTGCAGCAGTAAACTCACTACAAGAAGTAAGTATGGAGGAACTAGACCAAATTATTGGTGCCGGAAACGGAGTGGTTCTTACTCTTACTCATGAATGTAACCTAGCAACTTGGACAAAAAAACTAAAATGTTGCTAA	MKSTNNQSISEIAAVNSLQEVSMEELDQIIGAGNGVVLTLTHECNLATWTKKLKCC	MSIAQYALHDITKRYHDCVVLDRVGFSIKPGEKVGVIGDNGSGKSTLLKILAGRVEPDNGALTVVAPGGVGYLAQTLELPLDATVQDAVDLALSDLRELEAAMREAEAELGESDENGSERELSAGLQRYAALVEQYQARGGYEADVRVEVALHGLGLPSLDRDRKLGTLSGGERSRLALAATLASSPELLLLDEPTNDLDDRAMEWLEDHLAGHRGTVIAVTHDRVFLDRLTTTILEVDSGSVTRYGNGYEGYLTAKAVERERRLREYEEWRAELDRNRGLITSNVARMDGIPRKMSLSVFGHGAYRRRGRDHGAMVRIRNAKQRVAQLTENPVHAPADPLSFAARIDTAGPEAEEAVAELTDVRVAGRLAVDSLTIRPGERLLVTGPNGAGKSTLLRVLSGELEPDGGSVRVGCRVGHLRQDETPWAPGLTVLRAFAQGREGYLEDHAEKLLSLGLFSPSDLRRRVKDLSYGQRRRIEIARLVSDPMDLLLLDEPTNHLTPVLVEELEQALADYRGAVVVVTHDRRMRSRFTGARLTMGDGRIAEFSAG	10.18	gnl|BL_ORD_ID|113|hsp_num:0	128		
BGC0000547.1|Salivaricin_11 # 11811 # 14594 # 1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=10bp;gc_cont=0.298	BGC0000547.1|Salivaricin_11 	11811	14594	+	Loose	500	27.335	APH(6)-Ia	38.71	3002657	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(6)	ATGAAGTATAACCAACTATATGAACAATTTGATAAGTTTCCTTTATTTATAATTAAACAGAAATTTAATTACAAATCATTGGAGAATTCAAATAATAGAAAAGTACTAGAAAAAATTATATTAGATTACTATAGGCCAACATTGATTTACTTAATTAATGAAAAAAGGGTCAATGGCGAGCTAAAAGGTAACACTCCTGAGGAACGCTATGATTATTTTAATCAAGAACTATGTGGTAGTGGTAAAATTTTTGGAGAAATTGAAATAAGATTTCCAGAAATTAATGATAGAATCGAATTAATAGTGAAAAAATACTTAGACTTGCACGAGCGAGTGAAATCTACTTTTGTAAAAGACTTTCGGTTTTTGTGTGATAATAAATTTTTACATTCTGATAAATTGAAACCTGATTTGGATAAGCTTGAAATTGAAGTTACGGGTGATATACATGACGGAGCGGGAGTGTGTATTATCAGTTATAATAATCAAAAGGTAGTATATAAAAGAAAAAGTTCTATAGCAAATAGATTTCTTCGAAAGATAGATTTAATGGTAAGTGAATTTTTTAACGAAGAGATTCGTTTTATTCCAAACATTTTAGATAGAGATGGATATTTTTGGGAACAATATATAAATAATCAAAAATTGAAAAATGCTAATGAGGCCAGGGAATACTACACGAATATGGGTTTCCTATTGTTTTATGCGTATATTTTTAATATTTCAGATTTACATTTTGAAAATATTCTTTCTTCTGGGAAATCGCCAATTTTAGTTGACGTAGAAACTCTCTTTAGTACATCACCATTTGAAATAATAGCTGATAACTTTGCAACCAAGGAGATTACTCAAAGAAGCCGATCCTCGGTACTTTCATCAGGATTACTTCCTATTTCTGAAGCAGAAAAAATATTTGGAGGAGATTTAAGTGGGATCCTTGGTGGAACACTAGTTAATGAATTTAAAACAGTCATTAATAACTACAGAGATGATATTAGAATTGAAAAAGTTGTTCAGGCAACAAAATATCAATCTCATCTGCCATTCTTTGAATATCTTGGTCAGAAGGAATATTTAGTAGCTACTAATTATGTAAATGACATAATAGCTGGTTTTAAGTTAGTGAGTGATTTTTTTCTTAATCATAAGGAAGAAATTCTGGAAGTGTATCAGCAATATTCAGATTTAAAAACACGAATATTGTTTAGAAATACTCATGAATATGACGTAGTTAGTCAGTTGCTTATTTCTCCAATATATTCCCAAAAACAAGATTTACTTTTTAAAAAAATGTCAGAGAAGCTAAGTCACTATGATAGTAGTAAATTGTGTGAATCAGAAGTTAGACAATTACTCAGTATGGATATACCATCTTTCTATATTGAAGCTAATTCTACAATAGTTACCGATGGATATTCGGATGTTTGGAAAATAAGGAAAACTCCCTTGTATTCTGTTACAGAGAAACTTAACAAACTAACTGAAGATAAGATATCTGAACAAGTTGAATTAATAAGATTTTCACTTCAAGCTGATCGTGATTCTGAGAGTACAGAAATGCAGGAACTGTATAAAAAATATGATGATTTTAGAAATGAAGAGAATATCATGATTAATGCTTTGAATAACCTTGTAGATGAGATACTTGCAAAAATGTACCTAGACCCAGATGATGAAAGTATTAATTGGATGACTTTAAAAGTTAATGATCATAACAATTTTGAATTGGTTCCAATGGATAATTCAATTTATGATGGTATCTCGGGGGTAGCATTAAGTTTAATAGAATGTTATTCTTTGTTAGATAAAAATAGAAAAAGAAAAGTTTATAGATGTTTGTGTTATTTGTTTAAAACACTTGTAAATGTGTATTCTAATATTTTAGATATGACCTACTATGTTGGAAGATTAGGGATACTATCAACCTTAGTAAGAATATCTCAAATTACCAAACAAGAAATACCACAAAAAATATTAAATAGTAAAGTTTCTTTGATTAATCAGGCTTTGCAAAATACACCAGCGGATTTTTTAACTGGATTTTCGAGTTCAATACTAGCTTGTGAAGAGGACGAATACTCAGAAGAGTTTCTTCGAACTATGATAAATCGCTTCAAAGAACTTAAACAATATGACAGCAATCATAACTACATTTATTGGGGAAAAGAAGAAAGTAATAATGTTAGCTTAGCACATGGAAATGCAGGTATCGAAATATCATTATTATATTTAGCCGGAAAACTCAAGAGTAGAGATGCTAAGGAAATGTATGAGGATGCTAAAAAATTTGATGATAAGCAGAGATTAGACCAAGGCTGGATAGATAAGAGGTTTTCGGATTCAAATGCTCAATGGTGTCATGGGTCAACAGGAGTATTAATATCTAGGTTAGCTCAGTTAAAGTTAAATCAGGAATTTAAAATTTTAAGTATACAAGAAGAATCCTTGCTTGTAGAAGATATTCAGCATGCAATAAAGCAAATTATCTTAATAGGATTTGATATGAATAATTTTACTTTATGTCACGGAGTCGGTGGAAACCTTTTAGCATTAACTTACTATAATAATTTGTATGGGGGTGAAAATAGCTCGGAATTAGAAGAAATCATTAATTCGGAGTATAGAAAAATGCTTTCATTTGGAATTAAATATGGTTGGATGTGCAGTCTTAATACCAACTTCGATTCTTATGGTTTAATGACAGGACTTGCAGGAATAATTTACTCAGTATCAAAATATTTGAAAAGTGATTCTTCGCTTGAAATTTTAACTCCGGTCTTTTGA	MKYNQLYEQFDKFPLFIIKQKFNYKSLENSNNRKVLEKIILDYYRPTLIYLINEKRVNGELKGNTPEERYDYFNQELCGSGKIFGEIEIRFPEINDRIELIVKKYLDLHERVKSTFVKDFRFLCDNKFLHSDKLKPDLDKLEIEVTGDIHDGAGVCIISYNNQKVVYKRKSSIANRFLRKIDLMVSEFFNEEIRFIPNILDRDGYFWEQYINNQKLKNANEAREYYTNMGFLLFYAYIFNISDLHFENILSSGKSPILVDVETLFSTSPFEIIADNFATKEITQRSRSSVLSSGLLPISEAEKIFGGDLSGILGGTLVNEFKTVINNYRDDIRIEKVVQATKYQSHLPFFEYLGQKEYLVATNYVNDIIAGFKLVSDFFLNHKEEILEVYQQYSDLKTRILFRNTHEYDVVSQLLISPIYSQKQDLLFKKMSEKLSHYDSSKLCESEVRQLLSMDIPSFYIEANSTIVTDGYSDVWKIRKTPLYSVTEKLNKLTEDKISEQVELIRFSLQADRDSESTEMQELYKKYDDFRNEENIMINALNNLVDEILAKMYLDPDDESINWMTLKVNDHNNFELVPMDNSIYDGISGVALSLIECYSLLDKNRKRKVYRCLCYLFKTLVNVYSNILDMTYYVGRLGILSTLVRISQITKQEIPQKILNSKVSLINQALQNTPADFLTGFSSSILACEEDEYSEEFLRTMINRFKELKQYDSNHNYIYWGKEESNNVSLAHGNAGIEISLLYLAGKLKSRDAKEMYEDAKKFDDKQRLDQGWIDKRFSDSNAQWCHGSTGVLISRLAQLKLNQEFKILSIQEESLLVEDIQHAIKQIILIGFDMNNFTLCHGVGGNLLALTYYNNLYGGENSSELEEIINSEYRKMLSFGIKYGWMCSLNTNFDSYGLMTGLAGIIYSVSKYLKSDSSLEILTPVF	MSSSDHIHVPDGLAESYSRSGGEEGRAWIAGLPALVARCVDRWELKRDGGVRSGEASLVVPVLRADGTRAALKLQMPREETTAALIGLRAWGGDGMVRLLDHDEESSTMLLERLDGSRTLASVEDDDEAMGVLAGLLNRLHSVPAPPGLRGLGEIAGAMVEEVPSAVDSLADPEDRSRLRGWASAVAELVGEPGDRVLHWDLHYENVLAAEREPWLAIDPEPLVGDPGFDLWPALDTGWERIEATGDARRVVRRRFDLLTESLELDRGRAAGWTLARLLQNTLWDIEDGLTAIAPSQIAVAEALAKP	301.95	gnl|BL_ORD_ID|1412|hsp_num:0	1500		
BGC0000547.1|Salivaricin_12 # 14611 # 16689 # 1 # ID=1_12;partial=00;start_type=ATG;rbs_motif=GGGG;rbs_spacer=7bp;gc_cont=0.275	BGC0000547.1|Salivaricin_12 	14611	16689	+	Loose	1190	105.531	novA	21.5	3002522	protein homolog model	n/a	n/a	aminocoumarin antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGAAAGTAATTCTACAAAATAATGAAGAGGACTGTTTACTAGCTTGTTACACAATGCTATTGAATGATTTAGGCTATAAAGTACCTTTGTACGAGGTTTATGAAAGAGATTCACTTCCAGCTGATGGCTTGAGTGTTTCCTATTTACTGACTCTGAATAAAAACTTTAATGTAGATATTAAGGCATATAAGGCTAACTTTGATGAAGTTATTAGTCTAATACGTGTTAGAGGTAATAATAGGGTGATTGTTCATTGGAATAATGATCATTTTGTTGTTCTAGAAAAAATAACCAAAAATTATATAAAAATTGTGGATCCTGCAATAGGAAGAATTAAATTTAGTAAGGATGAATTTTTAGAACACTATTCTGGAACGGTTATTACCGTATTACCGACCGTTGATTTTCATCGTCAAAAAGTGAGGACGCTATTTTTTAAATATTTTAAAAACACACTGGAAGTAAGAGCAATTTTCTCTTTTTTGATTTCGTTACTTTTGATTGAAATTAGTGTTTTGCTATTTTCAATTGTGATAAGAAATATGGTGGCTGGAAATTTAAAATTTATTGCAAGTCTTCTCTTATTGTTTACTATTATATTACTACAAATTGTTGGATATTATATTAAGAATTTTGCGCTAGAAAAATATAATAGTAATTTTGATAAATCTTACACAACTATCTTATTTAAGAGATTGCTCAATAAACCATTACTATATTTTAGAAATCATACCAATGGAAGTATTTCTGAAAAAATAAGTTTCAGAACGACATTGAGAGATAGTGTTGCAACTAAACTAATCCCTTCAATAGTAAGTCTAGTTTCATCATTCGTAATTTTTATATATTTGGTCATAATCTCTTTTAGACTAACTATAATATTAGTTTCTATGATTGTATTATATTCTTTAATATCATCTGTTTTATATTATAAGCAGAACGAATATAATCAATCTTATCTACAATATCTAATTGATTTTAACTCAGATTTTCAATCTGATCTAGAAGATATAGATTACATTAAAGTAATGAGAAACGAGAGGGAAACGGAAGATAGATGGACAAAAAATAATGATCGTTTGACAAGCAAATATTCCCAAATTTTAAAAGTTGAAAATTTTGTTCAACTTTTTGGAAGTATATTTAGCTATTTTAGTTTATCAATTGTTATATTAGCAGTAATTTATAATAATAAATTTTTTAATGTTTCAATAGCAGATTTAGTATTATATCAAACAAGTATTTCATTATTGATTTCATCTATTGAACAAGTGAAAACCTCAATTTTTGAAATAGCACGATTAGCTATATATGCTGAAAAGCAGGGGGATATACTAAAAGAAAATTTACCAATAAATGTTAATTTTGACTTAGATTCAAACTATATAATTCAGACAGAAAATTTAAACTTTGGTTATGGAAATGAATCACTGTATAAACCAGTTAATTTGAAAATTAATCAAGGTGAAAAGATAGCAATTATAGGTAAATCAGGTAGTGGTAAATCTACATTGTTATTATTATTGACTGGCATGTTGAGACATTCTGGCAAGATTACATATAATAGTGAACATCTAGAAAACTATATGGGAGTAATCTTGCAAAATATGACATTGAAAAAAGGAAGTGTATTAGAAAACTTTGAATATGACTCTCCTGATTTAACTAAGCTATCAAAAATACTTGTTGATACCACAGCCGATGAGGTCATTGCTAAACTTCCCAATAAATTGCAATCGAAGTTGTTAAAACAGGGAAAGAATCTTTCGGGAGGACAAATCCAGAAATTATTAATTGCCAAATCATTGTTGAAAGGTGAAAAAATGATTTTTTGGGATGAAGCTTTTAGTAATTTGGATGAAATGAGTAAAGATAAGATTTATGAAAATGTTTTATTGGGAAGTTTCTATAAGGATAAAACGATGTTAATTGTAAGTCACCACTTGGATATTGTGAACTACGTTGATAGTGTTATCTTTATAAATGATGAAACAGGAGAAGTCATCAAATCAACTCACGAAGATTTACAAAAGAACAACTTGGATTACAAGAGATTTATTTGTAATAAAGGTGTCTAA	MKVILQNNEEDCLLACYTMLLNDLGYKVPLYEVYERDSLPADGLSVSYLLTLNKNFNVDIKAYKANFDEVISLIRVRGNNRVIVHWNNDHFVVLEKITKNYIKIVDPAIGRIKFSKDEFLEHYSGTVITVLPTVDFHRQKVRTLFFKYFKNTLEVRAIFSFLISLLLIEISVLLFSIVIRNMVAGNLKFIASLLLLFTIILLQIVGYYIKNFALEKYNSNFDKSYTTILFKRLLNKPLLYFRNHTNGSISEKISFRTTLRDSVATKLIPSIVSLVSSFVIFIYLVIISFRLTIILVSMIVLYSLISSVLYYKQNEYNQSYLQYLIDFNSDFQSDLEDIDYIKVMRNERETEDRWTKNNDRLTSKYSQILKVENFVQLFGSIFSYFSLSIVILAVIYNNKFFNVSIADLVLYQTSISLLISSIEQVKTSIFEIARLAIYAEKQGDILKENLPINVNFDLDSNYIIQTENLNFGYGNESLYKPVNLKINQGEKIAIIGKSGSGKSTLLLLLTGMLRHSGKITYNSEHLENYMGVILQNMTLKKGSVLENFEYDSPDLTKLSKILVDTTADEVIAKLPNKLQSKLLKQGKNLSGGQIQKLLIAKSLLKGEKMIFWDEAFSNLDEMSKDKIYENVLLGSFYKDKTMLIVSHHLDIVNYVDSVIFINDETGEVIKSTHEDLQKNNLDYKRFICNKGV	MKSALSTWKPSDRPPDPTLPEPPAQLRRIFRLFRPYRGRLAVVGLLVGASSLVAVASPFMLREILDTAIPQGRTGLLSLLALGMILTAVLSSVFGVVQTLISTTVGQRVMHDLRTAVYAQLQRMPLAFFTRTRTGEVQSRIANDIGGMQATVTSTATSLVSNLTAVIATVVAMLALDWRLTVVSLLLLPVFVWISRRVGRERKRITLQRQKQMATMAATVTESLSVSGILLGRTMGRADSLTRSFAEESERLVDLEVRSNMAGRWRMSVIGIVMAAMPAVIYWAAGFVLQSGGTVVSIGTLVAFVSLQQGLFRPAVSLLATGVQMQTSLALFQRIFEYLDLPVDITEPERPVALDKVRGEVRFDGVDFSYEEKDGNTLHGLDLTVPAGGSLAVVGPTGSGKSTLSYLVPRLYDVTGGRVLLDGVDVRDLAFDTLARAVGVVSQETYLFHASVADNLRFAKPDATDEEIEKAARAAQIHEHIVTLPDGYDTLVGERGYRFSGGEKQRLAIARTILRDPPVLVLDEATSALDTRTEHAVQQAIDSLSEGRTTITIAHRLSTVRDADQIVVLDAGRIAERGTHEELIDRDGRYAALVRRDGAPAPAPVPARDERVGAA	112.52	gnl|BL_ORD_ID|1140|hsp_num:0	1210		
BGC0000547.1|Salivaricin_13 # 16744 # 17652 # 1 # ID=1_13;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=7bp;gc_cont=0.290	BGC0000547.1|Salivaricin_13 	16744	17652	+	Loose	570	221.861	bcrA	43.05	3002987	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGACAGAAGTAATAAAACTAAAAAAATTGAAGAAAAATTTTAAAGGAGTATCGTCAGTCGATTTAGAAGGACTTACAGTTAGAAAAGGTGAAATTTATGGTTTCCTTGGTCCTAATGGAGCAGGTAAAACCACGACAATGAAGATGATTCTATCATTAATTGAACCTACTTCTGGTTCAATTGAAATAATGAATACTCCAATTAACAGATCGAACGATTATTTAAAATATATAGGTTCAATGATTGAAGAACCTTCTTACTATCCGAATTTAACAGGTTACGAAAATCTATTAGTTTTTCAAAAAATGTTAGGTTTTAAAGAAGAGAATATTTTAAAAACACTTGAACTTGTGGGGCTATCAGAAGAAAAAAATAGAAAAAAATTAGTAAAAGCGTATTCTTTAGGTATGAAACAGCGGTTAGCTCTAGCATTTGCTTTAGTAAAAGAACCTCAGATATTATTATTAGATGAACCTACAAATGGATTAGATCCCTCAGGTATTCATGAGATACGTGAATTGATTATTCGTTTGGCTAAAGATAAGGGATTAACAGTTTTCATTTCTAGTCATATTCTATCTGAAATAGAGCAGATTGCTGACAGGGTTGGAATTATAAATCATGGGAGATTAGTATACGAGGGAGAAATTGAAAAAATAAATACTAATAATTGGGTAGAAATTGAAGGAAAATTTGACATTGAAAAATTAAAAAATCTTTTTGGTAATCATTTTAGTAATAGAAAAGTGGAATATGATGCAAAACTTGTTAAAATCTGGAATACTAATAATGAGCAGATCGCTAATATAGTCCGTTCCTTGTTTGAATTAGACTTTCCAATTTTTCGTGTAGAACATAAAAAAGAAAATCTCGAAGATATATTTTTAGAATTAACTAAGGAGTTATAA	MTEVIKLKKLKKNFKGVSSVDLEGLTVRKGEIYGFLGPNGAGKTTTMKMILSLIEPTSGSIEIMNTPINRSNDYLKYIGSMIEEPSYYPNLTGYENLLVFQKMLGFKEENILKTLELVGLSEEKNRKKLVKAYSLGMKQRLALAFALVKEPQILLLDEPTNGLDPSGIHEIRELIIRLAKDKGLTVFISSHILSEIEQIADRVGIINHGRLVYEGEIEKINTNNWVEIEGKFDIEKLKNLFGNHFSNRKVEYDAKLVKIWNTNNEQIANIVRSLFELDFPIFRVEHKKENLEDIFLELTKEL	MSTIIKTTDLTKMYGSQKSVDHLNINVKQGDIYGFLGRNGAGKTTTIRMLLGLIKPTSGQIEIFGENFFKNKKEILRRIGSIVEVPGFYANLTARENLLINAKIIGIHKKNAIDEVLEIVGLQHETKKLVGKFSLGMKQRLGIARALLHYPELLILDEPTNGLDPIGIKEMRRLIHSLAKERNITIFISSHILSEIEQLVDHVGIIHEGKLLEEIPFDHLKKRNRKYLEFQLSDQNKAVVLMEQHFDIHDYEVHQDGIIRVYSHLGQQGKLNKLFVENGIDVLKITMSEDSLEDYFVKLIGGGTIG	98.69	gnl|BL_ORD_ID|322|hsp_num:0	345		
BGC0000547.1|Salivaricin_15 # 18406 # 19140 # 1 # ID=1_15;partial=00;start_type=ATG;rbs_motif=GAG;rbs_spacer=9bp;gc_cont=0.298	BGC0000547.1|Salivaricin_15 	18406	19140	+	Loose	600	23.8682	vanHF	35.71	3002945	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanH; glycopeptide resistance gene cluster	ATGAGACATTATACTTCAGCTGAATGGAAAAAACTGAATAAAATTCAGATTTTAATAGTCGGTGTTGTTTTTGTAGCATTATCAAGTTTTATCGGTTTAGGTACCTATTTTGCTAATCACTCAGTTTTAATTGATGGTACACAGGATAAAGTTATGTGGGGACAATTAACTTTCTATTATACTCAGATTCTCTATTCTCCAATGCTCGCAATTTTTATTGCAATATCTTTAACTCAAGAGTTTGAAAGAAAAAACTTGGAAATGTTATGTTCAAATGCAATATCTATCAAAAAGTTACTGATAAGCAAGCTTTTAACAGTTACTGTATTAGTTATTCCAATTCAACTTCTCATACTAATTGTTTATATAATAGCTTTAGAAGTAGCTGATGTCGAACTCTCTTCTTTTGTCCTATTAACTTTAAAATGGACACTTTTATCTATTTTGAGCTCTTTATCTATTTTATGCATACAAGCATTTGTCTATGCTAAAACTAGAAGCTTTGGTCAATCAATTGGTATTTCAGCTATCGGTGCTATGGGCGGGTTCGTTCTATTGTTTTTGAATGAAAACTTGAATAAATTTTATCCGTATTCTCAACCTATGGTAGCATTGAGAAGTAGGGCTTTAGATGATTTTTCATTATTAGAACTTACTATTTTTGTCTTTGTTAATCTTCTGTTTAGTGTGATTTTTTACAGATTAACATGTTATGAACTAGAAAAAAGAGGATAA	MRHYTSAEWKKLNKIQILIVGVVFVALSSFIGLGTYFANHSVLIDGTQDKVMWGQLTFYYTQILYSPMLAIFIAISLTQEFERKNLEMLCSNAISIKKLLISKLLTVTVLVIPIQLLILIVYIIALEVADVELSSFVLLTLKWTLLSILSSLSILCIQAFVYAKTRSFGQSIGISAIGAMGGFVLLFLNENLNKFYPYSQPMVALRSRALDDFSLLELTIFVFVNLLFSVIFYRLTCYELEKRG	MKNIGITIYGCERDEAEVFNELSPRFGVIPAITSSAVSETNAMLAPGNQCISVGHKSEISESILLALKESGVKYISTRSIGCNHIDVKAAESMGIAVGNVAYSPDSVADYTLMLMLMAIRNAKSIVSRAEKYDFRLDTVPGKELREMTVGVLGTGQIGKAVIERLRGFGCHVLAYGHSKEAAANYVSLNELLQKSDILTIHVPLGTDTYHMIGHEQIEAVKQGAFLINTARGGLVDTGALIKALENGRLGGAALDVLEGEEGLFYFDCTQKPIDNQLLLKLHKMPNVIITPHTAYYTGRALYDTVEKTILNCLEFERRETLE	75.78	gnl|BL_ORD_ID|1691|hsp_num:0	1790		
BGC0000547.1|Salivaricin_16 # 19650 # 19934 # -1 # ID=1_16;partial=00;start_type=TTG;rbs_motif=GGA;rbs_spacer=6bp;gc_cont=0.305	BGC0000547.1|Salivaricin_16 	19650	19934	-	Loose	250	22.7126	CrcB	24.59	3005049	protein homolog model	n/a	n/a		antibiotic efflux	multidrug and toxic compound extrusion (MATE) transporter	TTGTCGCTTTTTTTCACTCCCTTTATACTTCTATCCTTAAATAGTCTTTCAAAATTCCTATCAGATCAGAAATATCATTGTTATCTATTCGAACAAGCTATTGTAGGCTATATTGATTATTACAACAACAAACATATTAAGGTAAAACTAAAACAAAAAAGACAATCGCAAGAGACTTCAACCAAACCACACACAATTGCCTCTATACATCGTCTCATTAGAACAATGTATTACCTCATAACACATAACAAACTTTACGATTATACTTCTACCCAAAATTGCTAA	MSLFFTPFILLSLNSLSKFLSDQKYHCYLFEQAIVGYIDYYNNKHIKVKLKQKRQSQETSTKPHTIASIHRLIRTMYYLITHNKLYDYTSTQNC	MLNFTILIFVGGAFGAICRELLMLVVPRLSDGFPLDIFIANIIAAFLLGLCTSLYKRNRVNQYIHMMVATGIMGGLSTFSSFVSGAVEMMNEPLSALIAICYLVISLIVGFMAVELGLRLGSRVKPAPPMTHNRSTG	68.61	gnl|BL_ORD_ID|2839|hsp_num:0	3792		
BGC0000547.1|Salivaricin_18 # 21124 # 22455 # 1 # ID=1_18;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=12bp;gc_cont=0.412	BGC0000547.1|Salivaricin_18 	21124	22455	+	Loose	500	26.1794	CPS-1	28.95	3003716	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	CPS beta-lactamase	GTGACTATCGTTTCGAACTCTAATAAACTGTTTCCAAACGTGACAGTAGGTCAATCAAACGGTTCAAATACTAATGTCACTATCATTTCACAAGGAAATCAACAAAATAACTCAGGTTACCAAATCATCACAGGTGAGACTAAACCAAGTGTTGATTCGAACAATGCCAAGTCTTCATTTGTCCGTGTAGGCGAAAATCAATGGTATTATTACGACCAATATGGCCAAAAGGTCAAAGGTGAAAAGGTTATCGATGGTAAGGCTTATTACTTCCTTGAAAATGGTCTTCAAGCTCGTGACTCACTTGTTAAAGGTAGCGATGGCTACACTTATTACTATGATAAAAATGGCGTGAAAGCTATCAACGGTTTCTACGATTTTGCAGGTTACCGTAAGGATGTCCGCTATTTCGACTGTTATGGTCACATGGCTACTGGTCTTCTTGAAATGTGTGGCACAACCTTCTACTTTGATACACAAACAGGTATCCAAGCGAAAGACAAGTTTATTCGCTTCTCAGATGGCCGTATCCGTTACTTCATCCCTAATACTGGTAACATGGCTGTAAATACCTTTGTTCAAAATAAAGAAAACCAAGCTTGGTACTACCTAGATGAACATGGTTACGCTGTGACAGGAAAACGCATCATCAATGGTAAAGAATACTGCTTTGACTCAGAAGGCCGTCAAATCAAAGGTCAGATGATGCAACAAGGCAACAAGCATTACTACATTTCAGCTCAAACAGGTGAAATGGCTGTTTCACGCTTTATCTTTGAAAACAACAACTGGTATTATGCGGATGCTTTTGGTTGCCTCGTTCAAGGTGCAAAAGTAATTGATGGTAAACTCTATTACTTCAATAAAGACCACAGCCAATTAAAAGGTGGCTGGGCTGAAGGGCGTTACTATGATGCCGTTACTGGTCAAGCAGTCATTAACCAATTCATTCAAATTGCGGCTAACCAATGGGCTTACCTTAACCAAGATGGTCACAAAGTAACAGGTCTTCAAAACATTAACAATAAAGTTTACTACTTTGGTAGCAACGGTGCTCAAGTCAAAGGTAAATTGCTCACTGTCCAAGGTAAGAAATGCTACTTTGATGCCCACACTGGTGAGCAAGTGGTGAACCGCTTTGTCGAAGCTGGCCGTGGTTGCTGGTATTACTTTAACGCAGCAGGTCAAGCAGTGACTGGGAAACAGGTCATCAATGGCAAACAACTTTACTTCGACGGTTCAGGTCGTCAAGTGAAAGGACGTTATGTCTATGTTGGTGGTAAACGCCTTTTCTGCGATGCCAAAACTGGTGAATTGAGACAGCGTCGCTAA	MTIVSNSNKLFPNVTVGQSNGSNTNVTIISQGNQQNNSGYQIITGETKPSVDSNNAKSSFVRVGENQWYYYDQYGQKVKGEKVIDGKAYYFLENGLQARDSLVKGSDGYTYYYDKNGVKAINGFYDFAGYRKDVRYFDCYGHMATGLLEMCGTTFYFDTQTGIQAKDKFIRFSDGRIRYFIPNTGNMAVNTFVQNKENQAWYYLDEHGYAVTGKRIINGKEYCFDSEGRQIKGQMMQQGNKHYYISAQTGEMAVSRFIFENNNWYYADAFGCLVQGAKVIDGKLYYFNKDHSQLKGGWAEGRYYDAVTGQAVINQFIQIAANQWAYLNQDGHKVTGLQNINNKVYYFGSNGAQVKGKLLTVQGKKCYFDAHTGEQVVNRFVEAGRGCWYYFNAAGQAVTGKQVINGKQLYFDGSGRQVKGRYVYVGGKRLFCDAKTGELRQRR	MRNLTLLFLLCLSFFGTAQTVTEPKNNPAEWSKDYEPFKIVGNLYYVGTYDLASYLIVTDKGNILINTGLADSYSTIKKNIEKFGFKYKDIKILTLTQAHYDHMGAMAQIKKETGAKLYVDEKDAAELKSGGKSDYEMGKYGVTFEPVHPDFLLKNNAKIKLGNTVLTLLHHPGHTKGSCSFLFETKEGNKNYKVLIANLPSIIIDHKFSDVKKYPTIQKDYGYTFEAMKKINFDVWVASHASQFDLHKKRKEGDSYNPKLFMDKENYFKRLKDLENDYLEKVKEDSAKK	152.76	gnl|BL_ORD_ID|2074|hsp_num:0	2231		
